T40.722D Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter

Name of the Condition

• Common name: Intentional self-harm from synthetic cannabinoids
• Medical terms: Synthetic cannabinoid poisoning, intentional self-harm, subsequent encounter

Summary

This ICD code applies to intentional self-harm involving synthetic cannabinoids during a subsequent encounter. It covers cases where a patient has previously received care for the same condition and is now receiving follow-up treatment. The code is used when the poisoning was deliberate and the encounter is not the initial or acute phase of care.

Causes

Intentional self-harm from synthetic cannabinoids typically results from deliberate ingestion, inhalation, or other exposure to these substances with the intent to cause harm. This may involve misuse of synthetic cannabinoid products or intentional overdose.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety, suicidal ideation)
• Prior episodes of self-harm or substance use
• Access to synthetic cannabinoid products
• Social or environmental stressors
• Lack of support systems or coping mechanisms

Symptoms

• Altered mental status or confusion
• Agitation, anxiety, or paranoia
• Nausea, vomiting, or abdominal pain
• Increased heart rate or palpitations
• Drowsiness, lethargy, or loss of consciousness
• Respiratory distress or seizures (in severe cases)
• Signs of self-inflicted injury or overdose

Diagnosis

Diagnosis involves a clinical evaluation, detailed history of the event, and assessment of the patient’s mental and physical status. Toxicology screens may be used to confirm synthetic cannabinoid exposure. Documentation should clarify the intent (self-harm) and the encounter type (subsequent).

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying mental health needs. This may include supportive care, medications to counteract effects, and referral to mental health services. Follow-up care is critical for ongoing support.

Prognosis and Follow-Up

Prognosis depends on the severity of the poisoning and the patient’s response to treatment. Follow-up care is essential to monitor for recurrence, address mental health concerns, and provide resources for prevention. Long-term outcomes vary based on individual circumstances.

Complications

• Respiratory failure or arrest
• Cardiac arrhythmias or cardiovascular collapse
• Seizures or neurological damage
• Worsening of mental health conditions
• Risk of future self-harm or overdose

Lifestyle & Prevention

• Secure storage of synthetic cannabinoid products to prevent access
• Education on the risks of intentional self-harm and substance misuse
• Encouragement of healthy coping strategies and support systems
• Regular mental health check-ins for at-risk individuals
• Avoidance of environments where synthetic cannabinoids are present

When to Seek Professional Help

Seek immediate medical attention if there are signs of overdose, altered consciousness, or self-harm. Contact a healthcare provider for follow-up care after an intentional self-harm event, even if symptoms seem mild. Mental health support should be sought to address underlying issues.

Tips for Medical Coders

Use this code for subsequent encounters related to intentional self-harm from synthetic cannabinoids. Document the intent (self-harm) and encounter type clearly. Ensure the code aligns with the patient’s clinical status and prior treatment history. Verify that the encounter is not initial or acute to avoid incorrect code assignment.